Racial Disparities in Infant Drug Testing: A Research Note

Black infants were tested for drug exposure at more than twice the rate of White infants. Among those tested, both groups had similar positive rates-approximately 20%. Clinical risk factors explain only 38% of the racial disparity in testing rates. The remaining 61% may reflect differential treatment or unmeasured clinician observations. These findings raise concerns about fairness and trust in clinical decision-making.